Advanced Search
Contact | Corporate | Help

Treatment of Head & Neck Cancer With Chemotherapy and Radiation

Sponsors:
  • Sarah Cannon Research Institute
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Head and Neck Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Bevacizumab
  • Drug: Erlotinib
Enrollment:
61

Additional information about NCT00392704.


SourceSolution © 2008-2012